Heartbeam, INC Form 4 insider transactions

Kenneth Harry Persen, Chief Technology Officer of HeartBeam, Inc., received 105,740 shares of common stock on July 24, 2026.

Tim Cruickshank, CFO of HeartBeam, Inc., received 167,760 shares of common stock on July 24, 2026.

Branislav Vajdic, President and a Director of HeartBeam, Inc., reported multiple transactions in common stock on June 15, 2026.

Director Richard Ferrari filed an amendment to his Form 4 to correct the number of shares acquired in HeartBeam's recent public offering.

HeartBeam CFO Tim Cruickshank purchased 31,250 shares of common stock as part of the company's recent public offering.

Director Willem Elfrink acquired 187,500 shares of HeartBeam, Inc. common stock at $0.80 per share in a public offering.

Director Michael R. Jaff acquired 31,250 shares of HeartBeam, Inc. common stock as part of a recent public offering.

Director Branislav Vajdic purchased 31,250 shares of HeartBeam, Inc. common stock at $0.80 per share.

Director Richard Ferrari purchased 62,500 shares of HeartBeam, Inc. common stock at $0.80 per share.

HeartBeam President Robert Paul Eno acquired 12,500 shares of common stock at $0.80 per share in a public offering.

Director Marga Ortigas-Wedekind acquired 25,000 shares of HeartBeam, Inc. common stock at $0.80 per share.

Director Mark E. Strome acquired 750,000 shares of HeartBeam, Inc. common stock at $0.80 per share.

HeartBeam, Inc. Director Marga Ortigas-Wedekind received a grant of 44,827 stock options with an exercise price of $1.43, vesting in two tranches.

HeartBeam, Inc. Director Richard Ferrari was granted 50,000 restricted stock units, vesting in two tranches by June 2026.

HeartBeam, Inc. Director and 10% Owner Mark E. Strome was granted 41,380 stock options with an exercise price of $1.43, vesting in two tranches.

HeartBeam, Inc. Director Michael R. Jaff was granted 20,689 Restricted Stock Units, vesting in two tranches by mid-2026.

HeartBeam, Inc. President and Director Branislav Vajdic was granted 61,932 stock options with an exercise price of $1.45 per share.

HeartBeam's CFO, Tim Cruickshank, was granted 53,104 stock options with an exercise price of $1.45, vesting in two tranches by June 2026.

HeartBeam, Inc. Director Willem Elfrink was granted 51,724 stock options with an exercise price of $1.43, vesting in two tranches by June 2026.

HeartBeam, Inc. Director Kenneth Warwick Nelson III reported the acquisition of 17,241 restricted stock units (RSUs) as part of the company's 2022 Equity Incentive Plan.

HeartBeam, Inc. Director George de Urioste was granted 51,724 stock options with an exercise price of $1.43, vesting in two tranches by June 2026.

HeartBeam, Inc. President Robert Paul Eno was granted 55,172 stock options with an exercise price of $1.45, vesting in two tranches in 2026.

HeartBeam Director and 10% owner Mark E. Strome filed a Form 4 indicating a planned sale of 250,000 common shares on December 17, 2025, under a 10b5-1 plan.

HeartBeam Director George de Urioste sold 57,146 shares of common stock in two transactions to cover tax withholding obligations related to RSU vesting.

HeartBeam's CFO, Tim Cruickshank, reported the beneficial ownership of 17,647 common shares and a grant of 23,333 restricted stock units.

HeartBeam Director Richard Ferrari filed a Form 4 detailing his direct and indirect common stock holdings and recent restricted stock unit grants.

HeartBeam, Inc. Director George de Urioste reported the acquisition of restricted stock units and stock options, aligning his interests with shareholders.

HeartBeam Director Michael R. Jaff reported the grant of 78,664 restricted stock units (RSUs) with future vesting dates, alongside current beneficial ownership of 75,120 common shares.

HeartBeam, Inc. President Robert Paul Eno was granted 24,242 Restricted Stock Units (RSUs) under the company's 2022 Equity Incentive Plan.

HeartBeam Director and 10% owner Mark E. Strome reports new grants of restricted stock units and stock options, alongside significant existing beneficial ownership.